155 related articles for article (PubMed ID: 37395191)
1. Fibrinolytic drugs induced hemorrhage: mechanisms and solutions.
Tang M; Hu C; Lin H; Yan H
Blood Coagul Fibrinolysis; 2023 Jul; 34(5):263-271. PubMed ID: 37395191
[TBL] [Abstract][Full Text] [Related]
2. Thrombolytic therapy for deep vein thrombosis: potential application of plasmin.
Marder VJ
Thromb Res; 2009; 123 Suppl 4():S56-61. PubMed ID: 19303506
[TBL] [Abstract][Full Text] [Related]
3. New thrombolytic strategy: bolus administration of tPA and urokinase-fibrinogen conjugate.
Maksimenko AV; Tischenko EG
J Thromb Thrombolysis; 1999 Jun; 7(3):307-12. PubMed ID: 10373713
[TBL] [Abstract][Full Text] [Related]
4. Thrombolytic therapy in patients with submassive pulmonary embolism.
Dalen JE
N Engl J Med; 2003 Jan; 348(4):357-9; author reply 357-9. PubMed ID: 12542064
[No Abstract] [Full Text] [Related]
5. Hemorrhagic complications of thrombolytic therapy.
Vujković Z; Racić D; Miljković S; Dajić V
Med Pregl; 2012; 65(1-2):9-12. PubMed ID: 22452232
[TBL] [Abstract][Full Text] [Related]
6. [Development of new thrombolytic substances].
Zeymer U; Neuhaus KL
Herz; 1994 Dec; 19(6):314-25. PubMed ID: 7843688
[TBL] [Abstract][Full Text] [Related]
7. [Role of plasminogen activators in the treatment of deep venous thrombosis].
Bollaert PE
Ann Cardiol Angeiol (Paris); 2002 Jun; 51(3):169-71. PubMed ID: 12471649
[TBL] [Abstract][Full Text] [Related]
8. Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19.
Whyte CS; Morrow GB; Mitchell JL; Chowdary P; Mutch NJ
J Thromb Haemost; 2020 Jul; 18(7):1548-1555. PubMed ID: 32329246
[TBL] [Abstract][Full Text] [Related]
9. Platelet function and fibrinolytic agents: two sides of a coin?
Callahan KP; Malinin AI; Gurbel PA; Alexander JH; Granger CB; Serebruany VL
Cardiology; 2001; 95(2):55-60. PubMed ID: 11423707
[TBL] [Abstract][Full Text] [Related]
10. New developments in thrombolytic therapy.
Collen D; Gold HK
Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
[TBL] [Abstract][Full Text] [Related]
11. The search for the ideal thrombolytic agent: maximize the benefit and minimize the risk.
Gardell SJ
Toxicol Pathol; 1993; 21(2):190-8. PubMed ID: 8210941
[TBL] [Abstract][Full Text] [Related]
12. Chronic kidney disease and bleeding complications after intravenous thrombolytic therapy for acute ischemic stroke.
Ovbiagele B; Smith EE; Schwamm LH; Grau-Sepulveda MV; Saver JL; Bhatt DL; Hernandez AF; Peterson ED; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):929-35. PubMed ID: 25249561
[TBL] [Abstract][Full Text] [Related]
13. Coronary thrombolysis: hemorrhagic complications.
Hirsh J
Can J Cardiol; 1993; 9(6):505-11. PubMed ID: 8221344
[No Abstract] [Full Text] [Related]
14. Intravenous thrombolytic therapy for acute ischemic stroke.
Wechsler LR
N Engl J Med; 2011 Jun; 364(22):2138-46. PubMed ID: 21631326
[No Abstract] [Full Text] [Related]
15. [Experience with the thrombolytic therapy of myocardial infarct].
Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
[No Abstract] [Full Text] [Related]
16. [Ischemic ictus during thrombolytic treatment in acute myocardial infarct].
Seijo-Martínez M; Pais A; Castro del Río M; Silva-Martínez M
Rev Neurol; 2000 Oct 16-31; 31(8):798-9. PubMed ID: 11082894
[No Abstract] [Full Text] [Related]
17. Thrombolytic-associated coagulopathy and management dilemmas: a review of two cases.
Illoh OC; Illoh K
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):605-7. PubMed ID: 18685447
[TBL] [Abstract][Full Text] [Related]
18. Diffuse Alveolar Hemorrhage as a Complication of Intrapleural Fibrinolytic Therapy.
Shah RM; Krochmal R; Pickering EM; Burrows W; Sachdeva A
J Bronchology Interv Pulmonol; 2017 Oct; 24(4):e54-e56. PubMed ID: 28957896
[No Abstract] [Full Text] [Related]
19. Optimal timing of thrombolytic therapy in acute ischaemic stroke.
Madden K
CNS Drugs; 2002; 16(4):213-8. PubMed ID: 11945105
[TBL] [Abstract][Full Text] [Related]
20. Predictors of in-hospital death and symptomatic intracranial hemorrhage in patients with acute ischemic stroke treated with thrombolytic therapy: Paul Coverdell Acute Stroke Registry 2008-2012.
Tong X; George MG; Yang Q; Gillespie C
Int J Stroke; 2014 Aug; 9(6):728-34. PubMed ID: 24024962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
